Skip to Main content Skip to Navigation
Journal articles

Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)

D. Bennabi A. Yrondi T. Charpeaud J.-B. Genty 1 S. Destouches S. Lancrenon 2 N. Allaili F. Bellivier 3 T. Bougerol 3 V. Camus 4 O. Doumy J.-M. Dorey 3 F. Haesebaert J. Holtzmann C. Lançon 5 F. Moliere I. Nieto C. Rabu R. Richieri 6 L. Schmitt 7 F. Stephan 8 G. Vaiva 9 M. Walter M. Leboyer 3 Wissam El-Hage 10 Bruno Aouizerate 3 E. Haffen 11 P.-M. Llorca 3 P. Courtet 12
1 CEP - Centre d'expertise de la performance Gilles Cometti [Dijon]
UB - Université de Bourgogne
2 Sylia Stat Lancrenon S.A.S.
3 Fondation FondaMental [Créteil]
4 GPL - Groupe d'étude des proliférations lymphoïdes
5 Hôpitaux Sud - Hôpital Sainte-Marguerite [CHU - APHM]
6 Departement de Psychiatrie
7 ERL 6230
8 DESY - Deutsches Elektronen-Synchrotron [Zeuthen]
9 LNFP - Laboratoire de Neurosciences Fonctionnelles et Pathologies
10 iBrain - Inserm U1253 - UNIV Tours - Imagerie et cerveau
11 NEURO - Laboratoire de Neurosciences Intégratives et Cliniques - UFC (UR 481)
12 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
Abstract : Background: Recommendations for pharmacological treatments of major depression with specific comorbid psychiatric conditions are lacking. Method: The French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental developed expert consensus guidelines for the management of depression based on the RAND/ UCLA Appropriatneness Method. Recommendations for lines of treatment are provided by the scientific committee after data analysis and interpretation of the results of a survey of 36 psychiatrist experts in the field of major depression and its treatments. Results: The expert guidelines combine scientific evidence and expert clinician's opinion to produce recommendations for major depression with comorbid anxiety disorders, personality disorders or substance use disorders and in geriatric depression. Conclusion: These guidelines provide direction addressing common clinical dilemmas that arise in the pharmacologic treatment of major depression with comorbid psychiatric conditions.
Keywords : Anxiety disorders Elderly Major depressive disorder Pharmacotherapy
Document type :
Journal articles
Complete list of metadata

Cited literature [39 references]  Display  Hide  Download
https://hal-univ-tours.archives-ouvertes.fr/hal-02524126
Contributor : Wissam El-Hage Connect in order to contact the contributor
Submitted on : Monday, March 30, 2020 - 10:39:02 AM
Last modification on : Friday, January 14, 2022 - 5:24:02 PM

File

Vignette du document
2019_Bennabi_BMC_Psychiatry_Co...
Publisher files allowed on an open archive

Licence

Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

UNIV-TOURS | UNIV-BOURGOGNE | UNIV-FCOMTE | COMUE-NORMANDIE | UNIROUEN | CNRS | GPMCND

Citation

D. Bennabi, A. Yrondi, T. Charpeaud, J.-B. Genty, S. Destouches, et al.. Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental). BMC Psychiatry, BioMed Central, 2019, 19 (1), pp.1-9. ⟨10.1186/s12888-019-2025-7⟩. ⟨hal-02524126⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles